The resulting peptide clamp is linked to the antibody via a protease-cleavable sequence sensitive to matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, which are frequently overexpressed in the tumor microenvironment. This evidence concerns the gene MMP9 and neoplasm.